Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Risk/Benefit Decisions Will Be Quantified With Metric From Contractor

Executive Summary

A recent request for proposals may signal a shift in FDA's approach to risk/benefit analysis and views on outcome measures, a move some see as bringing more transparency while also shielding the agency from criticism

You may also be interested in...



PDUFA V: Patients’ Opinions Could Get Formal Role In Review Decisions

FDA is looking to formally add patient perspectives to its analyses in drug application reviews as it continues exploring a more transparent risk-benefit analysis.

PDUFA V: Patients’ Opinions Could Get Formal Role In Review Decisions

FDA is looking to formally add patient perspectives to its analyses in drug application reviews as it continues exploring a more transparent risk-benefit analysis.

Death Vs. Symptomatic Relief – Weighing Risks And Benefits For Asthma Drugs

When discussing a drug's benefits and risks, there is more to the equation than just death, Judith Kramer, Duke University, pointed out during a meeting of three FDA advisory committees to discuss asthma indications for long-acting beta agonists

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS049992

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel